Quick Takeaways
- Capitalink Ltd. filed SCHEDULE 13G/A for Clearmind Medicine Inc. Common Shares, no par value per share (CMND).
- Disclosed ownership: 5%.
- Date of event: 09 Feb 2026.
Capitalink Ltd. - 09 Feb 2026 SCHEDULE 13G/A Report for Clearmind Medicine Inc. Common Shares, no par value per share (CMND)
- Filing Manager
- Capitalink Ltd.
- Reporting Manager
- Capitalink Ltd.
- Symbol
- CMND
- Shares outstanding
- 2,158,860 shares
- Disclosed Ownership
- 107,943 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 16 Mar 2026, 10:17:36 UTC
- Date of event
- 09 Feb 2026
- Previous filing
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Capitalink Ltd. disclosed 5% ownership in Clearmind Medicine Inc. Common Shares, no par value per share (CMND) on 09 Feb 2026."
What Changed
- Previous schedule filing date: 10 Dec 2025.
- Current filing was accepted on 16 Mar 2026, 10:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capitalink Ltd. | 5% | 107,943 | 107,943 | 0 | /s/ Lavi Krasney | Lavi Krasney/Chief Executive Officer |